Condition: Psoriasis · Atopic Dermatitis · Xerosis · Sponsor: Makati Medical Center
The goal of this clinical trial is to learn if a novel barrier topical product works to treat barrier dysfunction in adults. It will also learn about the safety of the novel barrier topical product. The main questions it aims to answer are: Does the novel barrier topical product improve skin hydration, skin sebum, redness, and pigmentation? Does it improve subjective dryness and itch? Researchers will compare the novel barrier topical product to petrolatum (a gold standard occlusive barrier repair agent) to see how they are comparable in treating skin barrier dysfunction. Participants will: Apply the novel barrier topical product or petrolatum twice a day for 28 days Visit the clinic once a week for checkups and tests Keep a diary of their application of the assigned product
This description comes directly from the study's public registry record.
Cristina C Verallo Rowell, MD, MBA · 639171478318 · ccvrowell@gmail.com
Vermen M Verallo-Rowell, MD · 639178373134 · vmvrmd@gmail.com
Always discuss trial participation with your own doctor first.
| VMV Skin Research Center & Clinics | Makati City, National Capital Region, Philippines | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07183423